Cargando…

Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome

Detalles Bibliográficos
Autores principales:	Bedognetti, Davide, Wang, Ena, Marincola, Francesco M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203509/ https://www.ncbi.nlm.nih.gov/pubmed/25340012 http://dx.doi.org/10.4161/onci.28727

Ejemplares similares

Prognostic signatures of breast cancer: Perou's molecular subtypes and Schmidt's metagenes
por: Cadenas, Cristina
Publicado: (2012)

Biomolecular Events in Cancer Revealed by Attractor Metagenes
por: Cheng, Wei-Yi, et al.
Publicado: (2013)

Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response
por: Li, Qiyuan, et al.
Publicado: (2011)

Metagenes Associated with Survival in Non-Small Cell Lung Cancer
por: Urgard, Egon, et al.
Publicado: (2011)

MetaGen: reference-free learning with multiple metagenomic samples
por: Xing, Xin, et al.
Publicado: (2017)

Immune gene signatures and tumor intrinsic markers delineate novel immunogenic subtypes of breast cancer
por: Miller, Lance D, et al.
Publicado: (2014)

Dual roles for immune metagenes in breast cancer prognosis and therapy prediction
por: Alistar, Angela, et al.
Publicado: (2014)

The MetaGens algorithm for metagenomic database lossy compression and subject alignment
por: Cervi, Gustavo Henrique, et al.
Publicado: (2023)

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer
por: Bertucci, François, et al.
Publicado: (2018)

Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response
por: Roelands, Jessica, et al.
Publicado: (2020)

Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity
por: Lee, Jack Y., et al.
Publicado: (2022)

MetaGene: prokaryotic gene finding from environmental genome shotgun sequences
por: Noguchi, Hideki, et al.
Publicado: (2006)

metagene Profiles Analyses Reveal Regulatory Element’s Factor-Specific Recruitment Patterns
por: Joly Beauparlant, Charles, et al.
Publicado: (2016)

Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles
por: Sitthirak, Sirinya, et al.
Publicado: (2022)

CROPPER: a metagene creator resource for cross-platform and cross-species compendium studies
por: Paananen, Jussi, et al.
Publicado: (2006)

Identification of metagenes and their Interactions through Large-scale Analysis of Arabidopsis Gene Expression Data
por: Wilson, Tyler J, et al.
Publicado: (2012)

DNA Repair Gene Expression Adjusted by the PCNA Metagene Predicts Survival in Multiple Cancers
por: Peterson, Leif E., et al.
Publicado: (2019)

A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
por: Patil, Shivaprasad, et al.
Publicado: (2022)

Toward the identification of genetic determinants of breast cancer immune responsiveness
por: Simeone, Ines, et al.
Publicado: (2015)

Prediction of Breast Cancer Metastasis by Gene Expression Profiles: A Comparison of Metagenes and Single Genes
por: Burton, Mark, et al.
Publicado: (2012)

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
por: Buffa, F M, et al.
Publicado: (2010)

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
por: Buffa, F M, et al.
Publicado: (2010)

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene
por: Buffa, F M, et al.
Publicado: (2010)

Machine Learning Model Based on Insulin Resistance Metagenes Underpins Genetic Basis of Type 2 Diabetes
por: Saxena, Aditya, et al.
Publicado: (2023)

CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2016)

Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk
por: Salerno, Elise P., et al.
Publicado: (2016)

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
por: Brettschneider, Johannes, et al.
Publicado: (2010)

Intratumoral CXCL13(+)CD8(+)T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma
por: Dai, Siyuan, et al.
Publicado: (2021)

The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma
por: Huang, Jian-Hang, et al.
Publicado: (2022)

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers
por: Rody, Achim, et al.
Publicado: (2009)

Identification of clinically predictive metagenes that encode components of a network coupling cell shape to transcription by image-omics
por: Sailem, Heba Z., et al.
Publicado: (2017)

A multivariate Th17 metagene for prognostic stratification in T cell non-inflamed triple negative breast cancer
por: Faucheux, L., et al.
Publicado: (2019)

Machine‐learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time
por: Liao, Xin, et al.
Publicado: (2019)

Classic and targeted anti‐leukaemic agents interfere with the cholesterol biogenesis metagene in acute myeloid leukaemia: Therapeutic implications
por: Chen, Fangli, et al.
Publicado: (2020)

Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma
por: Jiao, Fangdong, et al.
Publicado: (2020)

Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus
por: Ascierto, Maria Libera, et al.
Publicado: (2015)

CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE
por: Kinzler, Maximilian N., et al.
Publicado: (2023)

Entry and exit of chemotherapeutically-promoted cellular dormancy in glioblastoma cells is differentially affected by the chemokines CXCL12, CXCL16, and CX3CL1
por: Adamski, Vivian, et al.
Publicado: (2020)

Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications
por: Roelands, Jessica, et al.
Publicado: (2017)

MDM2 SNP309 polymorphism is associated with lung cancer risk in women: A meta-analysis using METAGEN
por: HE, WENWU, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c8i3u36e8jvk7sbm04qkruifvs